America’s tobacco giants ($45 billion in sales last year) hit a major impasse last month. After years of tobacco’s denials that smoking harms the public health, a federal appeals court concurred with the Federal Drug Administration that tobacco is an addictive drug subject to FDA regulation. Despite a recent industry victory in a major liability case, U.S. tobacco companies are newly and perhaps permanently on the defensive. Even some of...
The remainder of this article is only available to paid subscribers.
Print subscribers to Commonweal are entitled to free access to all premium online content. Click here to purchase a print subscription, or if you’re already a print subscriber, register now for premium access.
Online-only subscriptions provide access to all premium online articles for just $34/year or $2.95/month. Click here to subscribe.